{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:15:19Z","timestamp":1778278519289,"version":"3.51.4"},"reference-count":43,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["2017 CAN2017\/340"],"award-info":[{"award-number":["2017 CAN2017\/340"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2016\u201001176"],"award-info":[{"award-number":["2016\u201001176"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2016\u201002373"],"award-info":[{"award-number":["2016\u201002373"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018\u201002400"],"award-info":[{"award-number":["2018\u201002400"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The anti\u2010cancer potential of dipyridamole has been suggested from experiments, but evidence from population\u2010based studies is still lacking. We aimed to explore if dipyridamole use was related to a lower risk of lymphoid neoplasms. We identified individuals with prescription of aspirin after diagnosis of ischaemic cerebrovascular disease since 2006 by linking several Swedish registers. In these aspirin users, those with dipyridamole prescription were further identified as the study group and patients without dipyridamole were randomly selected as reference group with 1:1 ratio using a propensity score\u2010matching approach. After a median of 6\u00b767\u00a0years of follow\u2010up, a total of 46 patients with dipyridamole use developed lymphoid neoplasms with an incidence rate of 0\u00b749 per 1\u00a0000 person\u2010years, while the rate in the matched group was 0\u00b774 per 1\u00a0000 person\u2010years. As compared to non\u2010users, dipyridamole users were associated with a significantly decreased risk of lymphoid neoplasms [hazard ratio (HR)\u00a0=\u00a00\u00b765; 95% confidence interval (CI)\u00a0=\u00a00\u00b743\u20100\u00b798]. Specifically, the reduced risk was observed for non\u2010Hodgkin lymphomas (HR\u00a0=\u00a00\u00b764; 95% CI\u00a0=\u00a00\u00b742\u20100\u00b794), especially B\u2010cell lymphomas (HR\u00a0=\u00a00\u00b756; 95% CI\u00a0=\u00a00\u00b735\u20100\u00b788). Dipyridamole use was related to a lower risk of lymphoid neoplasms, indicating a clinical potential of dipyridamole to be an adjunct anti\u2010tumour agent against lymphoid neoplasms.<\/jats:p>","DOI":"10.1111\/bjh.17851","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T08:45:37Z","timestamp":1632386737000},"page":"690-699","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score\u2010matched cohort study"],"prefix":"10.1111","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7616-8622","authenticated-orcid":false,"given":"Wuqing","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Health Statistics School of Public Health Fujian Medical University Fujian China"},{"name":"Department of Clinical Sciences Malm\u00f6 Center for Primary Health Care Research Lund University Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6 Center for Primary Health Care Research Lund University Lund Sweden"},{"name":"Department of Family Medicine and Community Health Department of Population Health Science and Policy Icahn School of Medicine at Mount Sinai New York NY USA"},{"name":"Department of Functional Pathology Center for Community\u2010based Healthcare Research and Education (CoHRE) School of Medicine Shimane University Matsue Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6 Center for Primary Health Care Research Lund University Lund Sweden"},{"name":"Department of Family Medicine and Community Health Department of Population Health Science and Policy Icahn School of Medicine at Mount Sinai New York NY USA"},{"name":"Department of Functional Pathology Center for Community\u2010based Healthcare Research and Education (CoHRE) School of Medicine Shimane University Matsue Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguang","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6 Center for Primary Health Care Research Lund University Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1037"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2014.05.008"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2007.12.004"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000154607.90506.45"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4002"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.06.025"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-743187"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-19-0413"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.06.001"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104615"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/mc.21970"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-012-9506-0"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-12-0345"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.10.027"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12775"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2014.08.010"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032015"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-013023"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10079"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68734-5"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(96)00308-5"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805840"},{"key":"e_1_2_12_24_1","first-page":"CD001820","article-title":"Dipyridamole for preventing stroke and other vascular events in patients with vascular disease","volume":"3","author":"De Schryver EL","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31901"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912035"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-051672"},{"issue":"4","key":"e_1_2_12_28_1","first-page":"188","article-title":"Charlson comorbidity index: ICD\u20109 update and ICD\u201010 translation","volume":"12","author":"Glasheen WP","year":"2019","journal-title":"Am Health Drug Benefits"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60405-0"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.110.957951"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2607"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0033-4"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903485642"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.03.046"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-252668"},{"issue":"2","key":"e_1_2_12_36_1","first-page":"589","article-title":"Inhibition of PDE3B augments PDE4 inhibitor\u2010induced apoptosis in a subset of patients with chronic lymphocytic leukemia","volume":"8","author":"Moon E","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(99)00188-4"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282715"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28971"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0728"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-13-0240"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu176"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22031"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.06.008"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.17851","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.17851","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.17851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T22:41:40Z","timestamp":1692830500000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.17851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1111\/bjh.17851"],"URL":"https:\/\/doi.org\/10.1111\/bjh.17851","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"2021-08-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}